이버멕틴 암 연구에서 환자의 84.4%가 6개월 후 암이 완전히 사라지거나, 축소되거나, 진행이 멈춤

<span class="HwtZe" jsname="jqKxS" jsaction="mouseup:Sxi9L,BR6jm; mousedown:qjlr0e" lang="ko"><span jsname="txFAF" class="jCAhz ChMk0b" jsaction="agoMJf:PFBcW;MZfLnc:P7O7bd;nt4Alf:pvnm0e,pfE8Hb,PFBcW;B01qod:dJXsye;H1e5u:iXtTIf;lYIUJf:hij5Wb;tSpjdb:qAKMYb" jscontroller="BiTO4b"><span class="ryNqvb" jsname="W297wb" jsaction="click:PDNqTc,GFf3ac,qlVvte;contextmenu:Nqw7Te,QP7LD; mouseout:Nqw7Te; mouseover:PDNqTc,c2aHje">역대 최대 규모의 이버멕틴 암 연구에서 환자의 84.4%가 6개월 후 암이 완전히 사라지거나, 축소되거나, 진행이 멈췄다고 보고했습니다.</span></span> <span jsname="txFAF" class="jCAhz ChMk0b" jsaction="agoMJf:PFBcW;MZfLnc:P7O7bd;nt4Alf:pvnm0e,pfE8Hb,PFBcW;B01qod:dJXsye;H1e5u:iXtTIf;lYIUJf:hij5Wb;tSpjdb:qAKMYb" jscontroller="BiTO4b"><span class="ryNqvb" jsname="W297wb" jsaction="click:PDNqTc,GFf3ac,qlVvte;contextmenu:Nqw7Te,QP7LD; mouseout:Nqw7Te; mouseover:PDNqTc,c2aHje">저희 연구는 현재 국제 항암 연구소에서 동료 심사를 거쳐 출판되었습니다.</span></span></span><br><br><br><span class="HwtZe" jsname="jqKxS" jsaction="mouseup:Sxi9L,BR6jm; mousedown:qjlr0e" lang="ko"><span jsname="txFAF" class="jCAhz ChMk0b" jsaction="agoMJf:PFBcW;MZfLnc:P7O7bd;nt4Alf:pvnm0e,pfE8Hb,PFBcW;B01qod:dJXsye;H1e5u:iXtTIf;lYIUJf:hij5Wb;tSpjdb:qAKMYb" jscontroller="BiTO4b"><span class="ryNqvb" jsname="W297wb" jsaction="click:PDNqTc,GFf3ac,qlVvte;contextmenu:Nqw7Te,QP7LD; mouseout:Nqw7Te; mouseover:PDNqTc,c2aHje">플로리다주는 이버멕틴이 암을 치료할 수 있는지 알아보기 위한 연구를 시작합니다.</span></span></span><br> <div class="up_content_video"><video autoplay="" muted="" loop="" playsinline="" webkit-playsinline="" controls="" data-file_type="mp4" poster="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/498dd10afde34567aa672ea31e8321c5_11620212968_poster.jpg"><source type="video/mp4" src="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/498dd10afde34567aa672ea31e8321c5_11620212968.mp4"></video><div class="video_footer" style="display:none;"> </div></div><div class="up_content_video"><video autoplay="" muted="" loop="" playsinline="" webkit-playsinline="" controls="" data-file_type="mp4" poster="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/54b815483bca63fe2c8e77c9a7db38ee_11620212973_poster.jpg"><source type="video/mp4" src="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/54b815483bca63fe2c8e77c9a7db38ee_11620212973.mp4"></video><div class="video_footer" style="display:none;"> </div></div><br><img class="-up-content -lazy-image" alt="" org-width="1320" org-height="1760" src="/img/transparent.gif" data="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/f5b0f0111d450134fe7d8d0280fc023c_11620212986.jpg"><br><img class="-up-content -lazy-image" alt="" org-width="1320" org-height="1760" src="/img/transparent.gif" data="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/c0aaae202db64e9a77a3c4f38065912b_11620212988.jpg"><br><img class="-up-content -lazy-image" alt="" org-width="1320" org-height="1760" src="/img/transparent.gif" data="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/4f0708ae019b634fd3b00b8d4e0d0c15_11620212993.jpg"><br><img class="-up-content -lazy-image" alt="" org-width="1320" org-height="1760" src="/img/transparent.gif" data="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/68a3dbd9b55e92781abdbf73b19e45a2_11620212995.jpg"><br><img class="-up-content -lazy-image" alt="" org-width="1320" org-height="1760" src="/img/transparent.gif" data="https://ncache.ilbe.com/files3/attach/new/20260814/377678/2428629770/11620212933/63b732373d3be6658a3baca84a80d69a_11620212997.jpg"><br>

새로운 알림0개

첨부 [7]

새로운 알림0개 전체삭제

이버멕틴 암 연구에서 환자의 84.4%가 6개월 후 암이 완전히 사라지거나, 축소되거나, 진행이 멈춤

첨부 [7]

새로운 알림0개